Cogent Biosciences, Inc.
COGT· Nasdaq
Cogent Biosciences, Inc.
- Last sale
- Oct 1, 2026 · -1.34%
- Market cap
- $5.48B
- 173.52M shares
- Filings
- 613
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $269,780,000 | reported | |
| FY 2024 | 2024-12-31 | $232,658,000 | reported | |
| FY 2023 | 2023-12-31 | $173,755,000 | reported | |
| FY 2022 | 2022-12-31 | $121,627,000 | reported | |
| FY 2021 | 2021-12-31 | $55,913,000 | reported | |
| FY 2020 | 2020-12-31 | $25,738,000 | reported | |
| FY 2019 | 2019-12-31 | $43,709,000 | reported | |
| FY 2018 | 2018-12-31 | $38,285,000 | reported | |
| FY 2017 | 2017-12-31 | $29,832,000 | reported |
Cogent Biosciences, Inc. · CIK 1622229 · Engraved from SEC EDGAR
